Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $32,626 - $36,992
-680 Reduced 15.0%
3,854 $209 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $25,936 - $30,949
535 Added 13.38%
4,534 $233 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $3,299 - $3,689
-57 Reduced 1.41%
3,999 $232 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $258,407 - $286,921
4,056 New
4,056 $259 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gateway Wealth Partners, LLC Portfolio

Follow Gateway Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Wealth Partners, LLC with notifications on news.